FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to clinical pharmacology and psychopharmacotherapy and represents a method for prediction of clinical effectiveness in anxiolytics patients with Aphobazolum before therapy. Aphobazolum therapeutic efficacy is predicted by the average total activating and calming action of the preparation according to the patient's subjective assessment of the effect of single dose test doses (15 mg).
EFFECT: technical result of the invention is higher quality of individual prediction of the effectiveness of Aphobazolum therapy in the patients with anxiety disorders before the beginning.
1 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF AMIDE N-(6-PHENYLHEXANOYL) GLYCYL-L-TRYPTOPHANE (GB-115) AS AN AGENT HAVING ANXIOLYTIC PROPERTIES WITH AN ACTIVATING COMPONENT | 2018 |
|
RU2709013C1 |
| USE OF METHYL ETHER OF N-CAPROYL-L-PROLYL-L-TYROSINE (DILEPT) AS AGENT WITH PSYCHOSTIMULANT ACTIVITY | 2015 |
|
RU2593886C1 |
| ANTIDEPRESSIVE THERAPY | 2008 |
|
RU2379035C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH ROSACEA | 2022 |
|
RU2793793C1 |
| METHOD OF CORRECTION OF PSYCHOVEGETATIVE DYSFUNCTIONS AND PROPHYLAXIS OF NEURO- AND CARDIOTOXIC RESPONSES TO POLYCHEMICAL THERAPY IN PATIENTS WITH TUBERCULOSIS | 2007 |
|
RU2354371C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH LICHEN PLANUS | 2016 |
|
RU2629601C1 |
| METHOD OF TREATING CHRONIC DERMATOSES | 2018 |
|
RU2709534C1 |
| METHOD FOR PREDICTING THERAPY EFFICIENCY FOR PATIENTS WITH ADJUSTMENT DISORDERS WITH ANXIETY-DEPRESSIVE SYMPTOMATIC | 2018 |
|
RU2677867C1 |
| METHOD FOR TREATING ALOPECIAS WITH CONCOMITANT PSYCHOSOMATIC DISORDERS | 2020 |
|
RU2756002C1 |
| METHOD FOR PREDICTION OF PAXYL EFFECTIVENESS IN TREATING ANXIOUS DISORDERS | 2009 |
|
RU2394480C1 |
